AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Stellar Bridge Solutions launches consulting firm for smaller pharma companies
AGP
Stellar Bridge Solutions has launched in Miami to serve small and mid-sized pharma, life sciences, biotech and manufacturing companies that need enterprise-level strategy without the overhead.
Aseptic isolators market seen reaching $11.65 billion by 2030
AGP
The Business Research Company says the aseptic isolators market will grow from $7.12 billion in 2025 to $7.88 billion in 2026, with North America leading the market.
AES market projected to hit $9.55 billion by 2030
AGP
The Business Research Company says the atomic emission spectroscopy market will grow from $6.32 billion in 2025 to $6.88 billion in 2026, then reach $9.55 billion by 2030. Pharmaceutical testing, environmental monitoring and newer plasma-based…
Generations Skincare launches saffron vesicle serum in North America
AGP
Generations Skincare says it is the first company in North America to launch a skincare serum using saffron tepal-derived exosomal vesicle technology.
Analytical instrumentation market seen reaching $89.58 billion by 2030
AGP
The Business Research Company says the global analytical instrumentation market is set to grow from $61.45 billion in 2025 to $89.58 billion by 2030, driven by pharmaceutical R&D, lab automation and demand for precise testing tools.
RN Enterprises acquires Helping Hands Home Healthcare to expand Florida care
AGP
RN Enterprises said Tuesday it acquired Florida-based Helping Hands Home Healthcare, a move that expands its home-based care footprint and keeps existing patients on uninterrupted service.
Luminari CRO names Jake Knorr strategic advisor for AI push
AGP
Luminari CRO said July 21, 2026, that it has appointed Jake Knorr as strategic advisor and executive relationship officer to support commercialization of its AI-powered clinical development platform, LumiPath. The hire adds a seasoned life…
STK returns with AI-native smartphone for clinical trials
AGP
STK is re-entering the market with STK Helix, a 5G smartphone built for decentralized clinical trials and life sciences deployments.
Pathology imaging systems market seen reaching $2.29B by 2030
AGP
The pathology imaging systems market is projected to grow from $1.37 billion in 2025 to $2.29 billion by 2030, driven by AI-assisted diagnostics, cloud platforms and more clinical trials.
Pathology imaging systems market seen reaching $2.29 billion by 2030
AGP
The pathology imaging systems market is projected to rise from $1.37 billion in 2025 to $2.29 billion by 2030 as digital pathology, AI tools and cloud platforms expand.
Sulthanul Arif says AI modernization is cutting healthcare ops costs
AGP
Sulthanul Arif, a Data Engineering Senior Manager at Accenture and Principal AI Architect for a major U.S. healthcare organization, says an AI modernization program is delivering measurable savings and faster workflows.
Padcev market seen topping $3 billion by 2030
AGP
The Business Research Company says the global Padcev market is entering a high-growth phase, with sales projected to pass $3 billion by 2030. North America and the U.S. are expected to lead, while urothelial cancer remains the biggest use case and…
Jessica Figueroa opens home infusion pharmacy in West Springfield
AGP
Jessica Figueroa, a pharmacy leader with more than 15 years of experience, is opening a franchise-based home infusion pharmacy in West Springfield, Massachusetts.
Polivy market seen topping $5 billion by 2030
AGP
The Business Research Company says the Polivy market will exceed $5 billion in 2030, driven by wider use in diffuse large B-cell lymphoma and growing demand for antibody-drug conjugate therapies.
Peptide therapeutics market seen topping $222B by 2030
AGP
The Business Research Company projects the global peptide therapeutics market will pass $222 billion in 2030, driven by demand for obesity and diabetes treatments, regulatory approvals and GLP-1 research.
Pharma contact center market seen topping $5.1 billion by 2030
AGP
The global market for contact centers serving pharmaceutical companies is projected to grow from $2.95 billion in 2025 to $5.1 billion by 2030, driven by clinical trial activity, biologic drugs and patient support needs.
Fetal bovine serum market seen topping $1 billion by 2030
AGP
The Business Research Company says the global fetal bovine serum market is on track to pass $1 billion by 2030, driven by rising cell culture use, biopharmaceutical R&D and research funding.
Cytogam market seen topping $60 million by 2030
AGP
The Business Research Company projects the global Cytogam market will reach $0.06 billion by 2030, driven by rising transplant volumes, CMV prevention demand and broader use of immune globulin therapies.
Chimeric antibody market seen topping $10 billion by 2030
AGP
The Business Research Company says the global chimeric antibody market will cross $10 billion in 2030, driven by demand for targeted cancer immunotherapies and biologic treatments.
OPEN Health's Aeja Jackson highlighted for HEOR and RWE leadership
AGP
Aeja Jackson, PhD, an HEOR Writer at OPEN Health, is being recognized for translating complex health data into evidence that supports patient care, market access and regulatory work.
Sign up for:
Medical Industry Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.